Anne Worsoe

Anne Worsoe is the Head of Investor Relations & Communication at Ultimovacs ASA, a prominent biotech company specializing in developing a therapeutic cancer vaccine and a cutting-edge tech platform for cancer treatment. She has extensive experience as an executive and non-executive in various industries and global markets, including AI & software development, biotech, renewable energy, diplomacy, finance/venture capital, and management consulting. Anne has served on numerous company boards, both private and public, covering early-stage companies, LPs, and venture capital funds. She is also an angel investor in over 25 early-stage companies, with a keen interest in diverse teams tackling challenges in AI & deep tech, biotech, and sustainability.